A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
Condition: Chronic Hepatitis C InfectionInterventions: Drug: ABT-450/r/ABT-267; Drug: ABT-333; Drug: Ribavrin; Drug: Pegylated Interferon alpha 2-alpha (PegINF); Drug: TelaprevirSponsor: AbbVieActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials